Journal of Neuroscience and Neuropharmacology

Kelly T Dineley

Kelly T Dineley
Department of Neurology, Director, Rodent In Vivo Assessment Core
University of Texas Medical Branch, Galveston, Texas, USA


Dr. Kelly Dineley attended the University of the Pacific in Stockton, California, where she received her BA in 1983 (Biology) and her MS in 1986 (Cell Biology). In 1998, she received her PhD in Neuroscience from Baylor College of Medicine in Houston, Texas. Following a postdoctoral fellowship in the laboratory of Dr. J David Sweatt, Dr. Dineley joined the faculty ranks at the University of Texas Medical Branch (UTMB) in 2003. She has steadily funded her research with grants from the National Institutes of Health, the John Sealy Memorial Endowment Fund for Biomedical Research, the Dunn Foundation, the Brown Foundation, Inc., the Alzheimer’s Association, the American Health Assistance Foundation, the Peter F. McManus Foundation, and the Mohn Foundation.

Research Interest

 Alzheimer’s disease and Parkinson’s disease and related proteionopathies: amyloidopathies,tauopathies, synucleinopathies
 Cocaine abuse and addiction
 Animal models utilizing genetic and pharmacological manipulations
 Omics and bioinformatics approaches for the identification and validation of      novel mechanisms that underlie memory and cognitive deficits induced by     aging, neurodegenerative disease, and drug abuse
 Nicotinic acetylcholine receptors, nuclear receptors (PPAR), ERK MAPK,         CREB, CBP, calcineurin
 Neuroinflammation
 Protein-protein interactions